FR1314351A - Method for obtaining polio virus antigens - Google Patents
Method for obtaining polio virus antigensInfo
- Publication number
- FR1314351A FR1314351A FR711358A FR711358A FR1314351A FR 1314351 A FR1314351 A FR 1314351A FR 711358 A FR711358 A FR 711358A FR 711358 A FR711358 A FR 711358A FR 1314351 A FR1314351 A FR 1314351A
- Authority
- FR
- France
- Prior art keywords
- obtaining
- virus antigens
- polio virus
- polio
- antigens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
- A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32661—Methods of inactivation or attenuation
- C12N2770/32663—Methods of inactivation or attenuation by chemical treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR711358A FR1314351A (en) | 1956-03-26 | 1956-03-26 | Method for obtaining polio virus antigens |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR711358A FR1314351A (en) | 1956-03-26 | 1956-03-26 | Method for obtaining polio virus antigens |
Publications (1)
Publication Number | Publication Date |
---|---|
FR1314351A true FR1314351A (en) | 1963-01-11 |
Family
ID=8702756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR711358A Expired FR1314351A (en) | 1956-03-26 | 1956-03-26 | Method for obtaining polio virus antigens |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR1314351A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112312925A (en) * | 2018-03-30 | 2021-02-02 | 生物模仿公司 | Irradiation inactivated poliovirus, composition containing same and preparation method |
-
1956
- 1956-03-26 FR FR711358A patent/FR1314351A/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112312925A (en) * | 2018-03-30 | 2021-02-02 | 生物模仿公司 | Irradiation inactivated poliovirus, composition containing same and preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH513142A (en) | Process for preparing 2-hydroxy-4-methylthio-butyronitrile | |
FR1314351A (en) | Method for obtaining polio virus antigens | |
FR1177595A (en) | Further development of the ethylene polymerization process | |
FR1305951A (en) | Method for obtaining a stable antigen of the polio virus | |
FR1281205A (en) | Process for obtaining compounds of the pregnane series | |
FR1149991A (en) | New uranium alloys and process for obtaining these alloys | |
FR1123216A (en) | Emulsifiable preparation, process for obtaining it, and resulting emulsion | |
FR1179775A (en) | Process for obtaining arylaminophenols | |
FR1175109A (en) | Process for obtaining para-xylene | |
FR1171543A (en) | 17-keto-steroid ethinylation process | |
FR71405E (en) | Process for obtaining peptides | |
FR71873E (en) | Process for obtaining peptides | |
FR1140379A (en) | Process for obtaining secondary n-aryl-beta-haloalkylamines | |
FR1160107A (en) | Process for obtaining new copolymers | |
FR1166211A (en) | Process for obtaining tri- and tetra-chlorethylene | |
FR1261164A (en) | Process for obtaining a polyvitamin preparation | |
FR1169060A (en) | Process for obtaining asymmetric dialkylhydrazines | |
FR1178479A (en) | Process for obtaining glycerin by fermentation | |
FR1153567A (en) | Improved urea preparation process | |
FR1181317A (en) | Process for obtaining acrylonitrile polymers | |
DK91138C (en) | Method for the production of "infectious hepatitis" virus vaccine. | |
FR71118E (en) | Process for obtaining benzene | |
FR1215941A (en) | Process for obtaining improved plasticizers | |
FR1187670A (en) | Process for obtaining hydrazine | |
FR72157E (en) | Process for obtaining peptides |